Transcriptional activation of deoxyribonucleic acid polymerase α gene expression in MCF-7 cells by 17β-estradiol

Endocrinology

Volumn 142, Issue 3, 2001, Pages 1000-1008

  Samudio, Ismael ^a,b   Vyhlidal, Carrie ^a,b   Wang, Fan ^a   Stoner, Matthew ^a   Chen, Ichen ^a   Kladde, Michael ^b   Barhoumi, Rola ^a   Burghardt, Robert ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE ALPHA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA FOOTPRINTING; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION;

EID: 0035089857     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.3.8022     Document Type: Article

References (61)

1. Eukaryotic DNA polymerases in DNA replication and DNA repair
2. Cellular DNA polymerases
3. Initiation of DNA replication in eukaryotic cells
4. Gene expression of human DNA polymerase α during cell proliferation and the cell cycle
5. Human DNA polymerase α gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases
6. Human DNA polymerase α gene: Sequences controlling expression in cycling and serum-stimulated cells
7. Cell cycle-dependent regulation of human DNA polymerase α-primase activity by phosphorylation
8. Cell cycle-dependent phosphorylation of human DNA polymerase α
9. Cell cycle-dependent phosphorylation and dephosphorylation of the yeast DNA polymerase α-primase B subunit
10. CCAAT box-dependent activation of the TATA-less human DNA polymerase α promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein
11. Control of human breast cancer by estrogen, growth factors, and oncogenes
12. Growth regulation of normal and malignant breast epithelium
13. Growth factors in breast cancer
14. Growth factor synthesis and human breast cancer progression
15. Estrogen regulates activity of cyclin-dependent kinases and retnoblastoma protein phosphorylation in breast cancer cells
16. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution
17. 1-arrested human breast cancer cells
18. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2
19. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: Modulation of hormone-induced cell cycle enzymes
20. Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture
21. Hormonal regulation of de novo pyrimidine synthesis and utilization in human breast cancer cells in tissue culture
22. Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture
23. Purification and properties of estrogen-responsive cytoplasmic thymidine kinase from human breast cancer
24. Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells
25. Mechanisms of growth control in normal and malignant breast epithelium
26. Transcriptional control of thymidine kinase gene expression by estrogens and antiestrogens in MCF-7 human breast cancer cells
27. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
28. Estrogen-induced c-fos protooncogene expression m MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
29. Functional and physical interactions between the, estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes
30. Transcriptional activation of insulin-like growth factor binding protein 4 by 17β-estradiol in MCF-7 cells: Role of estrogen receptor-Sp1 complexes
31. Estrogen-induced retinoic acid receptor α1 gene expression: Role of estrogen receptor-Sp1 complex
32. 2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/ estrogen receptor interactions
33. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells
34. Transcriptional activation of c-fos protooncogene by 17β-estradiol mechanism of aryl hydrocarbon receptor-mediated inhibition
35. Estrogen does not inhibit 2,3,7,8-tetraclorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells
36. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
37. Chromatin structure mapping in vivo using methyltransferases
38. Direct study of DNA-protein interactions in repressed and active chromatin in living cells
39. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene
40. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription
41. Regulation of cathepsin D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells
42. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression
43. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor
44. Identification of a motif whhin the 5'-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression
45. Tamoxifen activation of the estrogen receptor/AP-1 pathway; potential origin for the cell-specific estrogen-like effects of antiestrogens
46. Functional synergy between the transcription factor Sp1 and the estrogen receptor
47. HTLV-1 Tax protein stimulation of DNA binding of bZ1P proteins by enhancing dimerization
48. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene
49. CDK-independent activation of estrogen receptor by cyclin D1
50. Triple synergism of human T-lymphotropic virus type 1-encoded tax. GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells
51. The human T-cell leukemia virus-1 transcriptional activator Tax enhances c-AMP-responsive element-binding protein (CREB) binding activity through interactions with the DNA minor groove
52. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element
53. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
54. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
55. Ligand-, cell- and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements
56. Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter
57. Sp1 binding sites and an estrogen response element halt-site are involved in regulation of the human progesterone receptor A promoter
58. COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat in human microglial cells
59. COUP-TF upregulates NGF1-A gene expression through an Sp1 binding site
60. Physical interactions between retinoic acid receptor and Sp1: Mechanism for induction of urokinase by retinoic acid
61. WAF1 cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300